Literature DB >> 36045196

Cell Cycle-Related Clinical Applications.

Md Gulam Musawwir Khan1, Yi Wang2,3.   

Abstract

The cell cycle is a highly regulated and orchestrated mechanism of life that ensures successive division of a cell and precise replication of cellular contents. Cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors are three of the most critical cell cycle regulatory proteins that enable the smooth progression of cells through the different phases of cell cycle before and after division. The alteration of cell cycle-related proteins causes aberration in the normal cell cycle process, which is one of the pivotal causes of cancer and other diseases. Targeting cell cycle components has proven to be a valuable therapeutic strategy and leads to the development of novel anticancer therapeutic. The purpose of this book chapter is to summarize the literature and discuss the clinical significance of cell cycle-related proteins in cancers and other diseases, with a focus on identifying potential targets as therapeutic interventions for cancer patients.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Cell cycle; Cyclin-dependent kinases; Cyclins; Senescence; Stem cells

Mesh:

Substances:

Year:  2022        PMID: 36045196     DOI: 10.1007/978-1-0716-2736-5_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

1.  The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.

Authors:  Pantelis Palaiologos; Dimosthenis Chrysikos; Stamatios Theocharis; Gregory Kouraklis
Journal:  Anticancer Res       Date:  2019-11       Impact factor: 2.480

2.  Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

Authors:  Khaled A Hassan; K Kian Ang; Adel K El-Naggar; Michael D Story; Janet I Lee; Diane Liu; Waun K Hong; Li Mao
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

Review 3.  Cell cycle proteins as promising targets in cancer therapy.

Authors:  Tobias Otto; Piotr Sicinski
Journal:  Nat Rev Cancer       Date:  2017-01-27       Impact factor: 60.716

Review 4.  Immunomodulation by anticancer cell cycle inhibitors.

Authors:  Giulia Petroni; Silvia C Formenti; Selina Chen-Kiang; Lorenzo Galluzzi
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 53.106

Review 5.  Cell cycle control in cancer.

Authors:  Helen K Matthews; Cosetta Bertoli; Robertus A M de Bruin
Journal:  Nat Rev Mol Cell Biol       Date:  2021-09-10       Impact factor: 94.444

Review 6.  Targeting cell-cycle machinery in cancer.

Authors:  Jan M Suski; Marcin Braun; Vladislav Strmiska; Piotr Sicinski
Journal:  Cancer Cell       Date:  2021-04-22       Impact factor: 38.585

7.  Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma.

Authors:  Jia Wang; Tong Yang; Gaofeng Xu; Hao Liu; Chunying Ren; Wanfu Xie; Maode Wang
Journal:  Transl Oncol       Date:  2016-11-16       Impact factor: 4.243

8.  Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.

Authors:  Xu Liping; Li Jia; Chen Qi; Yang Liang; Li Dongen; Jiang Jianshuai
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.411

Review 9.  Selective Autophagy Regulates Cell Cycle in Cancer Therapy.

Authors:  Kai Zheng; Zhendan He; Kaio Kitazato; Yifei Wang
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.